Suppr超能文献

循环 miR-583 和 miR-663 与慢性乙型肝炎的中医辨证相关。

Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B.

机构信息

Research Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Pudong, Shanghai 201203, China.

出版信息

Evid Based Complement Alternat Med. 2013;2013:751341. doi: 10.1155/2013/751341. Epub 2013 Mar 10.

Abstract

Traditional Chinese medicine (TCM) ZHENG as the key pathological principle is to understand the human homeostasis and guide TCM treatment. Here, circulating microRNAs (miRNAs) were utilized to differentiate between ZHENGs including liver-gallbladder dampness-heat syndrome (LGDHS) and liver-kidney yin deficiency syndrome (LKYDS) in chronic hepatitis B (CHB). Sera samples of CHB patients with LGDHS (n = 35), LKYDS (n = 24), and healthy controls (Ctrls, n = 21) were analyzed by microarray and real-time RT-PCR. Receiver-operator characteristic (ROC) curves were established to evaluate the levels of serum miRNA for discriminating LGDHS and LKYDS. The target genes of miRNAs were predicted by TargetScan. Gene Ontology (GO) and pathways were analyzed using DAVID tool. The results showed that 22 miRNAs were differentially expressed between LGDHS and LKYDS (fold change >2.0 and P < 0.01). Circulating miR-583 and miR-663 were significantly higher (P < 0.001) in CHB patients with LGDHS than those with LKYDS and Ctrls. ROC curve analysis revealed that miR-583 and miR-663 were sensitive and specific enough to distinguish LGDHS from LKYDS. Pathway enrichment analysis indicated that 354 putative targets for miR-583 and 68 putative targets for miR-663 were mainly involved in Axon guidance, Neurotrophin, and MAPK signaling pathway. miR-583 and miR-663 may be potential markers for ZHENG differentiation in CHB.

摘要

中医(TCM)证作为关键的病理原则,用于理解人体的内稳态并指导 TCM 治疗。在这里,循环 microRNAs(miRNAs)被用于区分乙型肝炎慢性(CHB)患者的证,包括肝胆湿热证(LGDHS)和肝肾阴虚证(LKYDS)。通过微阵列和实时 RT-PCR 分析了 35 例 LGDHS、24 例 LKYDS 和 21 例健康对照(Ctrl)CHB 患者的血清样本。建立了接收者操作特征(ROC)曲线,以评估血清 miRNA 区分 LGDHS 和 LKYDS 的水平。使用 TargetScan 预测 miRNA 的靶基因。使用 DAVID 工具分析基因本体论(GO)和途径。结果表明,LGDHS 和 LKYDS 之间有 22 个 miRNA 表达差异(倍数变化>2.0,P<0.01)。与 LKYDS 和 Ctrl 相比,LGDHS CHB 患者的循环 miR-583 和 miR-663 明显更高(P<0.001)。ROC 曲线分析表明,miR-583 和 miR-663 足以区分 LGDHS 和 LKYDS。途径富集分析表明,miR-583 的 354 个假定靶标和 miR-663 的 68 个假定靶标主要参与轴突导向、神经营养素和 MAPK 信号通路。miR-583 和 miR-663 可能是 CHB 证分化的潜在标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e607/3608186/dd02ac6338c7/ECAM2013-751341.001.jpg

相似文献

1
Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B.
Evid Based Complement Alternat Med. 2013;2013:751341. doi: 10.1155/2013/751341. Epub 2013 Mar 10.
3
Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers.
Chin Med. 2019 Nov 21;14:52. doi: 10.1186/s13020-019-0275-4. eCollection 2019.
4
Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B.
World J Gastroenterol. 2012 Oct 7;18(37):5188-96. doi: 10.3748/wjg.v18.i37.5188.
7
Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in Hepatitis-B-Caused Cirrhosis.
Evid Based Complement Alternat Med. 2012;2012:453503. doi: 10.1155/2012/453503. Epub 2012 May 29.
9
Biological Differentiation of Dampness-Heat Syndromes in Chronic Hepatitis B: From Comparative MicroRNA Microarray Profiling to Biomarker Identification.
Evid Based Complement Alternat Med. 2020 Jan 20;2020:7234893. doi: 10.1155/2020/7234893. eCollection 2020.
10
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes.
Evid Based Complement Alternat Med. 2020 Oct 31;2020:5956940. doi: 10.1155/2020/5956940. eCollection 2020.

引用本文的文献

1
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes.
Evid Based Complement Alternat Med. 2020 Oct 31;2020:5956940. doi: 10.1155/2020/5956940. eCollection 2020.
2
-Induced MiR-663a Alleviates Hepatic Stellate Cell Activation by Attenuating the TGF-/Smad Signaling Pathway.
Evid Based Complement Alternat Med. 2020 May 11;2020:3156267. doi: 10.1155/2020/3156267. eCollection 2020.
3
Biological Differentiation of Dampness-Heat Syndromes in Chronic Hepatitis B: From Comparative MicroRNA Microarray Profiling to Biomarker Identification.
Evid Based Complement Alternat Med. 2020 Jan 20;2020:7234893. doi: 10.1155/2020/7234893. eCollection 2020.
4
Identification of more objective biomarkers for Blood-Stasis syndrome diagnosis.
BMC Complement Altern Med. 2016 Sep 22;16(1):371. doi: 10.1186/s12906-016-1349-9.
5
Characteristic Analysis from Excessive to Deficient Syndromes in Hepatocarcinoma Underlying miRNA Array Data.
Evid Based Complement Alternat Med. 2013;2013:324636. doi: 10.1155/2013/324636. Epub 2013 Dec 8.

本文引用的文献

1
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis.
J Clin Invest. 2013 Jan;123(1):164-78. doi: 10.1172/JCI65124. Epub 2012 Dec 3.
2
The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.
Int J Hepatol. 2012;2012:328372. doi: 10.1155/2012/328372. Epub 2012 Oct 24.
3
Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B.
World J Gastroenterol. 2012 Oct 7;18(37):5188-96. doi: 10.3748/wjg.v18.i37.5188.
4
Evidence-Based ZHENG: A Traditional Chinese Medicine Syndrome.
Evid Based Complement Alternat Med. 2012;2012:246538. doi: 10.1155/2012/246538. Epub 2012 Aug 12.
5
An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis.
J Ethnopharmacol. 2012 Jun 1;141(2):549-56. doi: 10.1016/j.jep.2011.08.045. Epub 2011 Aug 30.
8
A translational study of circulating cell-free microRNA-1 in acute myocardial infarction.
Clin Sci (Lond). 2010 Apr 20;119(2):87-95. doi: 10.1042/CS20090645.
9
Serum miR-146a and miR-223 as potential new biomarkers for sepsis.
Biochem Biophys Res Commun. 2010 Mar 26;394(1):184-8. doi: 10.1016/j.bbrc.2010.02.145. Epub 2010 Feb 24.
10
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.
Eur Heart J. 2010 Mar;31(6):659-66. doi: 10.1093/eurheartj/ehq013. Epub 2010 Feb 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验